3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Advanced Solid Tumor
3
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Advanced Solid Tumour
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
7
Nivolumab
6
enfortumab vedotin
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
4
sacituzumab govitecan
3
Docetaxel
3
CTLA-4 Antigen
3
cabozantinib
2
Taxes
2
Paclitaxel
2
Gemcitabine
2
temsirolimus
1
relatlimab
1
lenvatinib
1
eribulin
1
avelumab
1
atezolizumab
1
Valproic Acid
1
Sirolimus
1
Single Person
1
Radiosurgery
1
Platinum
1
Immunoglobulin G
1
Disulfides
1
Cisplatin
1
Cetuximab
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
tislelizumab
×
30 days
×
Clear all
No trials found.